Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CYP1B1 gene: Implications in glaucoma and cancer
Arwa Alsubait, Wadha Aldossary, Mamoon Rashid, et al.
Journal of Cancer (2020) Vol. 11, Iss. 16, pp. 4652-4661
Open Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

Biological roles of cytochrome P450 1A1, 1A2, and 1B1 enzymes
Yeo‐Jung Kwon, Sangyun Shin, Young‐Jin Chun
Archives of Pharmacal Research (2021) Vol. 44, Iss. 1, pp. 63-83
Closed Access | Times Cited: 55
Association of Healthy Diet and Physical Activity With Breast Cancer: Lifestyle Interventions and Oncology Education
Tiantian Jia, Yufeng Liu, Yuanyuan Fan, et al.
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 40
Insights into CYP1B1-Related Ocular Diseases Through Genetics and Animal Studies
Elizabeth B. Bolton, Andy Drackley, Antionette L. Williams, et al.
Life (2025) Vol. 15, Iss. 3, pp. 395-395
Open Access
Polyhalogenated carbazoles (PHCZs) induce cardiotoxicity and behavioral changes in zebrafish at early developmental stages
Zhongkun Du, Kaixuan Hou, Tongtong Zhou, et al.
The Science of The Total Environment (2022) Vol. 841, pp. 156738-156738
Closed Access | Times Cited: 22
Deciphering the roles of aryl hydrocarbon receptor (AHR) in regulating carcinogenesis
Zhi Xiong Chong, Chean Yeah Yong, Han Kiat Ong, et al.
Toxicology (2023) Vol. 495, pp. 153596-153596
Open Access | Times Cited: 14
Cytochrome P450 and Other Drug-Metabolizing Enzymes As Therapeutic Targets
R. Foti
Drug Metabolism and Disposition (2023) Vol. 51, Iss. 8, pp. 936-949
Open Access | Times Cited: 12
Molecular genetics of primary open-angle glaucoma
Manoj Kumar Yadav, Aarti Sonia Bhardwaj, Anshu Yadav, et al.
Indian Journal of Ophthalmology (2023) Vol. 71, Iss. 5, pp. 1739-1756
Open Access | Times Cited: 12
Profiling of CYP4Z1 and CYP1B1 expression in bladder cancers
Yousef M. Al-saraireh, Fatemah O. F. O. Alshammari, Ahmed M. M. Youssef, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 30
Proteomic insight towards key modulating proteins regulated by the aryl hydrocarbon receptor involved in ovarian carcinogenesis and chemoresistance
Lubna Therachiyil, Paleerath Peerapen, Shahd M. Younis, et al.
Journal of Proteomics (2024) Vol. 295, pp. 105108-105108
Open Access | Times Cited: 2
Development of Novel N-Aryl-2,4-bithiazole-2-amine-Based CYP1B1 Degraders for Reversing Drug Resistance
Xiaoxuan Yao, Jianping Mao, Haoyu Zhang, et al.
European Journal of Medicinal Chemistry (2024) Vol. 272, pp. 116488-116488
Closed Access | Times Cited: 2
New Perspectives of CYP1B1 Inhibitors in the Light of Molecular Studies
Renata Mikstacka, Zbigniew Dutkiewicz
Processes (2021) Vol. 9, Iss. 5, pp. 817-817
Open Access | Times Cited: 19
Cytochrome P450 1B1 Overexpression in Cervical Cancers: Cross-sectional Study
Fatemah O. F. O. Alshammari, Yousef M. Al-saraireh, Ahmed M. M. Youssef, et al.
Interactive Journal of Medical Research (2021) Vol. 10, Iss. 4, pp. e31150-e31150
Open Access | Times Cited: 18
Structure-Based Drug Design and Synthesis of Novel N-Aryl-2,4-bithiazole-2-amine CYP1B1-Selective Inhibitors in Overcoming Taxol Resistance in A549 Cells
Jianping Mao, Dong Wang, Ping Xu, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 24, pp. 16451-16480
Closed Access | Times Cited: 10
Design of Cytochrome P450 1B1 Inhibitors via a Scaffold-Hopping Approach
Austin C. Hachey, Alexander D. Fenton, David K. Heidary, et al.
Journal of Medicinal Chemistry (2022) Vol. 66, Iss. 1, pp. 398-412
Closed Access | Times Cited: 9
Evaluation of CYP1B1, oxidative stress and phase II detoxification enzyme status in oral cancer progression model
Anirudha Bartake, Sachin C. Sarode, Sangeeta Palaskar, et al.
Journal of Oral Biology and Craniofacial Research (2024) Vol. 14, Iss. 2, pp. 169-174
Open Access | Times Cited: 1
Integrated meta-analyses of genome-wide effects of PM2.5 in human cells identifies widespread dysregulation of genes and pathways associated with cancer progression and patient survival
Anadi Bisht, Sagnik Dey, Ritu Kulshreshtha
The Science of The Total Environment (2024) Vol. 938, pp. 173448-173448
Closed Access | Times Cited: 1
Unraveling the role of heavy metals xenobiotics in cancer: a critical review
Sourav Pal, Sayed Mohammed Firdous
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
NNAT is a novel mediator of oxidative stress that suppresses ER + breast cancer
Cody Plasterer, Marharyta Semenikhina, Shirng‐Wern Tsaih, et al.
Molecular Medicine (2023) Vol. 29, Iss. 1
Open Access | Times Cited: 4
Deficiency in the Treatment Description of mTOR Inhibitor Resistance in Medulloblastoma, a Systematic Review
Hajar Alammar, Rayan Nassani, Mana Alshehri, et al.
International Journal of Molecular Sciences (2021) Vol. 23, Iss. 1, pp. 464-464
Open Access | Times Cited: 11
Polyherbal effect between Phyllanthus urinaria and Curcuma longa as an Anticancer and Antioxidant
Sapti Puspitarini, Nashi Widodo, Sri Widyarti, et al.
Research Journal of Pharmacy and Technology (2022), pp. 671-678
Closed Access | Times Cited: 7
Exploring the Molecular Mechanism of Qing Guang An Granule in Treating Glaucoma Using Network Pharmacology and Molecular Docking
Ou Chen, Houpan Song, Ya-Sha Zhou, et al.
Evidence-based Complementary and Alternative Medicine (2020) Vol. 2020, Iss. 1
Open Access | Times Cited: 8
Salinomycin induces cell cycle arrest and apoptosis and modulates hepatic cytochrome P450 mRNA expression in HepG2/C3a cells
Andressa Megumi Niwa, Simone Cristine Semprebon, Gláucia Fernanda Rocha D’Epiro, et al.
Toxicology Mechanisms and Methods (2021) Vol. 32, Iss. 5, pp. 341-351
Closed Access | Times Cited: 7
Polymorphisms in CYP1B1 gene and the risk of suffering Primary Open-Angle Glaucoma: Systematic review and meta-analysis
Noelia Calero-Dueñas, Milagros Mateos-Olivares, Fernando Ussa, et al.
European Journal of Ophthalmology (2022) Vol. 32, Iss. 4, pp. 1841-1849
Closed Access | Times Cited: 5
CYP1B1 converts procarcinogens into genotoxins in Saccharomyces cerevisiae
Akaash Kannan, Nicholas Perpetua, Michael Dolan, et al.
Mutation Research/Genetic Toxicology and Environmental Mutagenesis (2022) Vol. 874-875, pp. 503440-503440
Open Access | Times Cited: 5
Design, synthesis and biological evaluation of highly potent and selective CYP1B1 inhibitors
Haoyu Zhang, Ping Xu, Ting Wang, et al.
New Journal of Chemistry (2023) Vol. 47, Iss. 12, pp. 5680-5690
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top